Biocure Technology, Inc. (CURE.X.CX)
0.03
-0.02
(-40.00%)
CAD |
CNSX |
Dec 05, 16:00
Biocure Technology Enterprise Value: 0.6128M for Dec. 5, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | 3.466M |
| NanoSphere Health Sciences, Inc. | 0.3167M |
| Lobe Sciences Ltd. | 10.38M |
| Algernon Health, Inc. | 2.652M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0468M |
| Total Expenses (Quarterly) | 0.0468M |
| EPS Diluted (Quarterly) | -0.0029 |
| Earnings Yield | -84.67% |
| Normalized Earnings Yield | -84.67 |